Cardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call

Share this story

CHICAGO–(BUSINESS WIRE)–Cardio Diagnostics Holdings, Inc. will host an investor
conference call on Thursday, December 10, 2026, at 11 a.m. Central Time.

See full post here as originally published on this site

Leave a Comment

Your email address will not be published. Required fields are marked *

*